Collaborations

Spotlight Pathology offers a range of tools to help Clinical Research Organisations and pharmaceutical and biotech companies of any size to supercharge their own research with AI.

We develop highly customised machine learning solutions tailored to your specific application, allowing you to maximise the impact of your medical images.

Our state-of-the-art software allows you to maximise the impact of your medical images to:

detect cancer,
differentiate cell types and perform automated cell counts,
carry out spatial analyses,
quantify heterogeneity,
discover novel molecular biomarkers for patient risk stratification, and
combine insights from multi-modal datasets.

Our expert team can provide you with everything you need to adopt AI technology immediately. De-risk your medical imaging projects and empower your team by outsourcing your machine learning research to us.

Ongoing projects:

Spotlight Pathology is collaborating with the Northern England Haemato-Oncology Diagnostic Service and their Novopath laboratory along with the National Pathology Imaging Co-operative (NPIC) to develop a novel AI lymphoma diagnostic triage tool. Project supported by the National Institute of Health Research (NIHR i4i).

We are working with the Haematology Oncology Diagnostics Service at the Manchester University NHS Foundation Trust to digitise lymph node and trephine biopsies. Our Chief Medical Advisor Dr Richard Byers has also recently been awarded a place on its Clinical Entrepreneurship programme.

Academic and Clinical Partnerships

We currently have several active partnerships which provide us with access to digitised slides and associated diagnostic data, as well as advice on product and study design. These valuable links also allow us to collaborate on haematopathology publications regarding product efficacy, and we have applied for multi-partner research grants. Additionally, our academic and clinical partnerships enable us to provide sponsorship and co-supervision of PhD students.